Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 6c

Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• BuzzFeed sells shares to Byron Allen affiliate for $5.8 million
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink